Chronic Obstructive Pulmonary Disease (COPD)
What is COPD?
Chronic Obstructive Pulmonary Disease (COPD) refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema, chronic bronchitis, and in some cases asthma. In the United States, tobacco use is a key factor in the development and progression of COPD, but asthma, exposure to air pollutants in the home and workplace, genetic factors, and respiratory infections also play a role. In the developing world, indoor air quality is thought to play a larger role in the development and progression of COPD than it does in the United States.
LAS-MD-45: A study to evaluate the effectiveness of Aclidinum Bromide(a type of long acting bronchodilator) on COPD, chronic bronchitis and emphysema. You may qualify to participate if you 1) have COPD, bronchitis, or emphysema, 2) over 40 years old, 3) a current or former smoker.
Forest (ROF-MD-07): A 52-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Roflumilast 500 mcg on Exacerbation Rate in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Treated With a Fixed-Dose Combination of Long-Acting Beta Agonist and Inhaled Corticosteroid (LABA/ICS).
If you are interested in the study or more information, contact the CardioPulmonary Research Center at 314-439-LUNG (5864).